Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

September 20, 2022

Study Completion Date

October 1, 2022

Conditions
Sickle Cell DiseaseGenetic DiseaseHematologic DiseasesAnemia, Sickle Cell
Interventions
OTHER

Electronic Health Record (EHR) Embedded Individualized Pain Plan (IPP)

"The IPPs will be developed by the Sickle Cell Disease providers at each study site based on patients' outpatient chronic opioid use and analgesic agent normally required for treatment of VOE in the ED. The Sickle Cell Disease provider will review the IPP with the patient, then upload the IPP to the patient's EHR in a location that will be accessible by the patient and ED provider. Each participating site will train patients and Emergency Department (ED) providers on how to access the IPP in the Electronic Health Record. The following required elements will be included in the EHR-embedded IPP:~* Genotype~* Individual pain plan-preferred analgesic agent, route, dose and dosing interval, last update time~* Name and contact information for the SCD provider~If the enrolled patient has a VOE visit at a nonparticipating ED, the patient will be able to access their IPP via the web or the patient portal app through their EHR. However, data will not be collected from these visits."

Trial Locations (8)

10029

Icahn School of Medicine at Mount Sinai, New York

27710

Duke University, Durham

29425

Medical University of South Carolina, Charleston

30912

Georgia Regents University, Augusta

38105

St. Jude's, Memphis

60612

University of Illinois, Chicago

63110

Washington University, St Louis

94609

University of California San Francisco, Oakland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

RTI International

OTHER

lead

Duke University

OTHER

NCT04584528 - Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease | Biotech Hunter | Biotech Hunter